Abstract
Bone marrow stimulation techniques such as abrasion arthroplasty [1], Pridie drilling [2], and microfracture [3] attempt to use the natural wound repair response elicited by a blood clot originating from the bone marrow. Channels surgically made in the subchondral bone below the cartilage lesion permit access to marrow blood and blood components including stem cells intended to provide an environment for wound healing that ultimately leads to cartilage regeneration. Microfracture, which has been frequently used as a first-line treatment for small cartilage lesions, has the advantage of being simple and safe, cost-effective, and minimally invasive with a low morbidity rate [4, 5]. On the other hand, the procedure results in a mixed repair tissue with mainly fibrous or fibrocartilaginous properties [6–10], limited collagen type II and glycosaminoglycan (GAG) levels, and poor mechanical properties compared to native hyaline cartilage. Indeed, the long-term durability of this repair tissue has been questioned with many reports showing a failure of repair tissue and a return of associated clinical symptoms starting as early as 24 months posttreatment [8, 11, 12].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Johnson LL (1986) Arthroscopic abrasion arthroplasty historical and pathologic perspective: present status. Arthroscopy 2(1):54–69
Insall JN (1967) Intra-articular surgery for degenerative arthritis of the knee. A report of the work of the late K. H. Pridie. J Bone Joint Surg Br 49(2):211–228
Steadman JR, Rodkey WG, Singleton SB, Briggs KK (1997) Microfracture technique for full-thickness chondral defects: technique and clinical results. Oper Tech Orthop 7(4):300–304
Mithoefer K, Williams RJ 3rd, Warren RF, Potter HG, Spock CR, Jones EC, Wickiewicz TL, Marx RG (2006) Chondral resurfacing of articular cartilage defects in the knee with the microfracture technique. Surgical technique. J Bone Joint Surg Am 88(Suppl 1 Pt 2):294–304
Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG (2003) Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy 19(5):477–484
Frisbie DD, Trotter GW, Powers BE, Rodkey WG, Steadman JR, Howard RD, Park RD, McIlwraith CW (1999) Arthroscopic subchondral bone plate microfracture technique augments healing of large chondral defects in the radial carpal bone and medial femoral condyle of horses. Vet Surg 28(4):242–255
Knutsen G, Drogset JO, Engebretsen L, Grontvedt T, Isaksen V, Ludvigsen TC, Roberts S, Solheim E, Strand T, Johansen O (2007) A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 89(10):2105–2112
Mithoefer K, Williams R Jr, Warren RF, Potter HG, Spock CR, Jones EC, Wickiewicz TL, Marx RG (2005) The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. J Bone Joint Surg Am 87(9):1911–1920
Saris DB, Vanlauwe J, Victor J, Haspl M, Bohnsack M, Fortems Y, Vandekerckhove B, Almqvist KF, Claes T, Handelberg F, Lagae K, van der Bauwhede J, Vandenneucker H, Yang KG, Jelic M, Verdonk R, Veulemans N, Bellemans J, Luyten FP (2008) Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 36(2):235–246
Steadman JR, Rodkey WG, Rodrigo JJ (2001) Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop 391(Suppl):S362–S369
Kreuz PC, Steinwachs MR, Erggelet C, Krause SJ, Konrad G, Uhl M, Sudkamp N (2006) Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage 14(11):1119–1125
Vanlauwe J, Saris DB, Victor J, Almqvist KF, Bellemans J, Luyten FP (2011) Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med 39(12):2566–2574
Gomoll AH (2012) Microfracture and augments. J Knee Surg 25(1):9–15
Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Binette F, Selmani A (2000) Novel injectable neutral solutions of chitosan form biodegradable gels in-situ. Biomaterials 21:2155–2161
Di Martino A, Sittinger M, Risbud MV (2005) Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 26(30):5983–5990
Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ (2004) Chitosan chemistry and pharmaceutical perspectives. Chem Rev 104(12):6017–6084
Kurita K (2006) Chitin and chitosan: functional biopolymers from marine crustaceans. Mar Biotechnol (NY) 8(3):203–226
Shi C, Zhu Y, Ran X, Wang M, Su Y, Cheng T (2006) Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 133(2):185–192
Hoemann CD, Sun J, McKee MD, Chevrier A, Rossomacha E, Rivard GE, Hurtig M, Buschmann MD (2007) Chitosan-glycerol phosphate/blood implants elicit hyaline cartilage repair integrated with porous subchondral bone in microdrilled rabbit defects. Osteoarthritis Cartilage 15(1):78–89
Marchand C, Rivard GE, Sun J, Hoemann CD (2009) Solidification mechanisms of chitosan-glycerol phosphate/blood implant for articular cartilage repair. Osteoarthritis Cartilage 17(7):953–960
Chevrier A, Hoemann CD, Sun J, Buschmann MD (2007) Chitosan-glycerol phosphate/blood implants increase cell recruitment, transient vascularization and subchondral bone remodeling in drilled cartilage defects. Osteoarthritis Cartilage 15(3):316–327
Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J (1996) Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int J Pharm 145:231–240
Hoemann CD, Hurtig M, Rossomacha E, Sun J, Chevrier A, Shive MS, Buschmann MD (2005) Chitosan-glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects. J Bone Joint Surg Am 87(12):2671–2686
van den Berg WB, van Lent PL, van de Putte LB, Zwarts WA (1986) Electrical charge of hyaline articular cartilage: its role in the retention of anionic and cationic proteins. Clin Immunol Immunopathol 39(2):187–197
Iliescu M, Hoemann CD, Shive MS, Chenite A, Buschmann MD (2008) Ultrastructure of hybrid chitosan-glycerol phosphate blood clots by environmental scanning electron microscopy. Microsc Res Tech 71(3):236–247
Chen H, Chevrier A, Hoemann CD, Sun J, Ouyang W, Buschmann MD (2011) Characterization of subchondral bone repair for marrow-stimulated chondral defects and its relationship to articular cartilage resurfacing. Am J Sports Med 39(8):1731–1740
Muzzarelli RA (1997) Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol Life Sci 53(2):131–140
Varum KM, Myhr MM, Hjerde RJ, Smidsrod O (1997) In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr Res 299(1–2):99–101
Chevrier A, Hoemann CD, Sun J, Buschmann MD (2011) Temporal and spatial modulation of chondrogenic foci in subchondral microdrill holes by chitosan-glycerol phosphate/blood implants. Osteoarthritis Cartilage 19(1):136–144
Chen G, Sun J, Lascau-Coman V, Chevrier A, Marchand C, Hoemann CD (2011) Acute osteoclast activity following subchondral drilling is promoted by chitosan and associated with improved cartilage repair tissue integration. Cartilage 2(2):173–185
Hoemann CD, Chen G, Marchand C, Tran-Khanh N, Thibault M, Chevrier A, Sun J, Shive MS, Fernandes MJ, Poubelle PE, Centola M, El-Gabalawy H (2010) Scaffold-guided subchondral bone repair: implication of neutrophils and alternatively activated arginase-1+ macrophages. Am J Sports Med 38(9):1845–1856
Marchand C, Chen G, Tran-Khanh N, Sun J, Chen H, Buschmann MD, Hoemann CD (2012) Microdrilled cartilage defects treated with thrombin-solidified chitosan/blood implant regenerate a more hyaline, stable, and structurally integrated osteochondral unit compared to drilled controls. Tissue Eng Part A 18(5–6):508–519
Goldring MB, Goldring SR (2010) Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 1192:230–237
Gomoll AH, Madry H, Knutsen G, van Dijk N, Seil R, Brittberg M, Kon E (2010) The subchondral bone in articular cartilage repair: current problems in the surgical management. Knee Surg Sports Traumatol Arthrosc 18(4):434–447
Minas T, Gomoll AH, Rosenberger R, Royce RO, Bryant T (2009) Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques. Am J Sports Med 37(5):902–908
Pestka JM, Bode G, Salzmann G, Sudkamp NP, Niemeyer P (2012) Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint. Am J Sports Med 40(2):325–331
McNickle AG, L’Heureux DR, Yanke AB, Cole BJ (2009) Outcomes of autologous chondrocyte implantation in a diverse patient population. Am J Sports Med 37(7):1344–1350
Zaslav K, Cole B, Brewster R, DeBerardino T, Farr J, Fowler P, Nissen C (2009) A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: results of the Study of the Treatment of Articular Repair (STAR) clinical trial. Am J Sports Med 37(1):42–55
Chen H, Hoemann CD, Sun J, Chevrier A, McKee MD, Shive MS, Hurtig M, Buschmann MD (2011) Depth of subchondral perforation influences the outcome of bone marrow stimulation cartilage repair. J Orthop Res 29(8):1178–1184
Frisbie DD, Morisset S, Ho CP, Rodkey WG, Steadman JR, McIlwraith CW (2006) Effects of calcified cartilage on healing of chondral defects treated with microfracture in horses. Am J Sports Med 34(11):1824–1831
Brun P, Dickinson SC, Zavan B, Cortivo R, Hollander AP, Abatangelo G (2008) Characteristics of repair tissue in second-look and third-look biopsies from patients treated with engineered cartilage: relationship to symptomatology and time after implantation. Arthritis Res Ther 10(6):R132
Welsch GH, Mamisch TC, Zak L, Blanke M, Olk A, Marlovits S, Trattnig S (2010) Evaluation of cartilage repair tissue after matrix-associated autologous chondrocyte transplantation using a hyaluronic-based or a collagen-based scaffold with morphological MOCART scoring and biochemical T2 mapping: preliminary results. Am J Sports Med 38(5):934–942
Acknowledgements
BST-CarGel® has been developed by Piramal Healthcare Bio-Orthopedics (formerly BioSyntech Canada Inc.). We are indebted to Professors Michael Buschmann and Caroline Hoemann, the inventors of BST-CarGel®, along with the Biomaterials and Cartilage Laboratory at Ecole Polytechnique of Montreal, who established the basic scientific foundation for BST-CarGel®. We are grateful to Dr. Jun Sun and Dr. Mark Hurtig for their animal surgery expertise. We thank Drs. Nicolas Duval and Pierre Ranger for their contributions with the pilot clinical use of BST-CarGel®. The critical efforts of the BST-CarGel® Clinical Study Group, including the investigators, sub-investigators, research coordinators, and physiotherapists who tirelessly contributed to the success of the clinical trial are warmly acknowledged. Other clinical trial activities carried out by Cato Canada (Montreal), MRI activities by VirtualScopics (Rochester, NY) and Qmetrics (Rochester, NY), and statistical expertise by Dr. Alex Yaroshinsky (San Andreas, CA) are appreciated.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 ESSKA
About this chapter
Cite this chapter
Restrepo, A., Méthot, S., Stanish, W.D., Shive, M.S. (2014). BST-CarGel®: An Enhanced Bone Marrow Stimulation Treatment. In: Shetty, A.A., Kim, SJ., Nakamura, N., Brittberg, M. (eds) Techniques in Cartilage Repair Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41921-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-41921-8_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41920-1
Online ISBN: 978-3-642-41921-8
eBook Packages: MedicineMedicine (R0)